Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.
about
Clinical Phenotypes in Heart Failure With Preserved Ejection FractionIron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction.Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.Update on heart failure with preserved ejection fraction.Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary studyNew strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trialGender disparities in red blood cell transfusion in elective surgery: a post hoc multicentre cohort study.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Heart failure with preserved ejection fraction: current understandings and challenges.Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.Single-dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo-controlled study (PRACTICE-ASIA-HF).
P2860
Q28073079-479B575D-622A-4AC2-AFA1-E0E63E7F8DCCQ28088503-C221A51B-36A1-40AC-A23C-23C00EB70163Q30435143-35F5A481-C0E1-43AE-90A6-E750E4A7E95AQ30952502-663EE14F-919D-4CE0-8F3F-8FF52C72CA25Q33640339-955B9346-9CD3-4325-8F88-B4D4C7C58419Q33992679-3423DC5B-EB7D-46C7-BC58-8420737FE792Q34375466-C1C7ACC9-679F-42EA-B5EC-F67027F61710Q37276822-7285F6D9-AB0A-4658-8C2C-C6C01DFD0BBFQ37330335-762F6CC5-40FF-4FA5-BEB0-E9C7A4E9EA60Q37516990-56D517F4-B8E6-4B8B-B3A2-52BBF5630BB7Q37633991-058B0A96-98EB-4B5A-98AD-A3B22C4C1DCEQ38217344-5BEB7524-FD88-4A7A-92A9-5D3A0A608CE6Q38743215-372A08E8-4AA1-429D-A6BA-02B020DA3961Q49972496-DC6BFF51-CCA4-4E1C-B1F5-EA8582642432
P2860
Treating anemia in older adults with heart failure with a preserved ejection fraction with epoetin alfa: single-blind randomized clinical trial of safety and efficacy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Treating anemia in older adult ...... trial of safety and efficacy.
@ast
Treating anemia in older adult ...... trial of safety and efficacy.
@en
type
label
Treating anemia in older adult ...... trial of safety and efficacy.
@ast
Treating anemia in older adult ...... trial of safety and efficacy.
@en
prefLabel
Treating anemia in older adult ...... trial of safety and efficacy.
@ast
Treating anemia in older adult ...... trial of safety and efficacy.
@en
P2093
P2860
P1476
Treating anemia in older adult ...... trial of safety and efficacy.
@en
P2093
Bibhas Chakraborty
Donna Mancini
Mathew S Maurer
Sergio Teruya
Stephen Helmke
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.112.969717
P577
2012-12-20T00:00:00Z